UTHR technical analysis
UTHR Technical Analysis
Analysis date
July 17, 2026
Market
NasdaqGS (USD)
Daily cutoff
July 16, 2026
Reliability
Passed
Informational use only. This page is not investment advice.
Data verification
UTHR Data Verification
Cross-validating the latest completed daily bar across independent sources.
- Symbol
- UTHR
- Market
- NasdaqGS
- Currency
- USD (US Dollar)
- Latest completed bar
- July 16, 2026
No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.
| Source | Latest Close | Date | Difference | Status |
|---|---|---|---|---|
| Financial Modeling Prep (FMP) | 357.84 | July 16, 2026 | - | Verified |
| Massive API (independent) | 357.84 | July 16, 2026 (previous close) | 0.00% | Verified |
Bottom line
UTHR Technical Analysis Summary
UTHR (United Therapeutics) presents a constructive technical picture with bullish bias on both daily and weekly timeframes. Price at 357.84 trades above SMA20 (340.15) and SMA50 (332.78) on the daily chart, while remaining comfortably above SMA200 (298.44), confirming a well-established multi-year uptrend. RSI14 at 58.42 on daily and 56.17 on weekly indicates healthy bullish momentum without overbought conditions. The daily MACD shows a positive alignment with the MACD line at 7.45 above the signal line at 4.92, and a rising histogram of 2.53, signaling steady upward momentum. The weekly MACD confirms this with the MACD line at 18.33 above the signal line at 14.67 and a positive histogram of 3.66. Key support rests at the 20-day low of 318.72 and SMA50 at 332.78. Resistance is at the 52-week high of 408.56 and the 20-day high of 372.01. The stock is trading near the upper half of its 52-week range at 55.1%, suggesting room for further upside. Volume has been near average, providing reasonable confirmation of the current trend.
Multi-timeframe dashboard
Multi-Timeframe Technical Dashboard
Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.
Daily (July 16, 2026)
- Trend
- Bullish. Price at 357.84 is above SMA20 (340.15, +5.20%), SMA50 (332.78, +7.53%), and SMA200 (298.44, +19.89%). All major moving averages are aligned bullishly with the SMA20 above SMA50, confirming a well-established uptrend. SMA200 continues to slope upward, supporting the long-term bullish structure.
- Momentum
- Bullish. RSI14 at 58.42 is in bullish territory above the 50 midline but below the 70 overbought threshold, suggesting room for further upside. MACD line at 7.45 is above the signal line at 4.92, with a positive and rising histogram of 2.53, confirming steady bullish momentum.
- Volatility
- Moderate. ATR14 at 9.82 (2.74% of price) reflects normal daily fluctuations for a mid-cap biotech stock. Bollinger Bands (320.45 to 363.21) are moderately wide with price trading in the upper half of the range, consistent with the prevailing uptrend.
- Volume
- Near average. Latest volume of 312,400 is 92.4% of the 20-period average (338,200), indicating normal participation levels with no unusual accumulation or distribution patterns.
Assessment
The daily chart shows a healthy uptrend with price well above all key moving averages. The bullish alignment of SMAs, positive MACD, and RSI in neutral-bullish territory all support the constructive outlook. Price is approaching the 20-day high of 372.01 but remains below the 52-week high of 408.56. Volume confirmation is adequate. A sustained move above 372.01 would signal near-term strength, while a move below SMA20 at 340.15 would suggest short-term weakness.
Weekly (July 13, 2026 week)
- Trend
- Bullish. Price at 354.12 is above SMA20 (325.67), SMA50 (308.44), and SMA200 (249.17). All weekly moving averages maintain an upward slope, reflecting a sustained multi-year uptrend. The SMA200 at 249.17 is significantly below current price, confirming the strength of the long-term trend.
- Momentum
- Bullish. RSI14 at 56.17 is in bullish territory above the 50 midline, indicating steady upward momentum without extreme readings. MACD line at 18.33 is above the signal line at 14.67, with a positive histogram of 3.66, confirming consistent bullish momentum on the weekly scale.
- Volatility
- Moderate. ATR14 at 16.51 (4.66% of price) reflects typical weekly ranges for a biotech stock in an established uptrend. Bollinger Bands (293.71 to 377.53) show price in the upper portion of the weekly range.
- Volume
- Slightly below average. Weekly volume of 1,647,800 is 87.6% of the 20-week average (1,881,400), indicating slightly reduced participation but not at concerning levels.
Assessment
The weekly chart strongly reinforces the bullish daily view. Price trades well above all key SMAs with all averages sloping upward. The SMA200 at 249.17 provides a strong long-term support reference. RSI at 56.17 leaves room for further upside before approaching overbought levels. The positive MACD histogram confirms steady weekly momentum. The 52-week position at 55.1% shows the stock is in the middle-upper half of its range, not yet extended. The weekly structure supports a continued bullish outlook as long as price holds above the SMA20 at 325.67.
Key indicators
UTHR Key Technical Indicators
RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.
| Indicator | Daily | Weekly |
|---|---|---|
| RSI (14) | 58.42 | 56.17 |
| MACD (12, 26, 9) | 7.45 / 4.92 / 2.53 | 18.33 / 14.67 / 3.66 |
| ATR (14) | 9.82 (2.74%) | 16.51 (4.66%) |
| Bollinger Bands (20, 2) | 320.45 - 363.21 | 293.71 - 377.53 |
| SMA (20) | 340.15 | 325.67 |
| SMA (50) | 332.78 | 308.44 |
| SMA (200) | 298.44 | 249.17 |
Price structure
UTHR Price Structure and Returns
Price performance across multiple lookback periods and 52-week position.
| Metric | Daily | Weekly |
|---|---|---|
| Current Price | 357.84 | 354.12 |
| 1-Period Return | +0.82% | +1.45% |
| 5-Period Return | +2.34% | +3.61% |
| 20-Period Return | +6.18% | +11.24% |
| 60-Period Return | +14.77% | +22.45% |
| 252-Period Return | +31.82% | +43.56% |
| 52-Week Low | 219.82 | 219.82 |
| 52-Week High | 408.56 | 408.56 |
| 52-Week Position | 55.10% | 53.80% |
Key levels
UTHR Support and Resistance Levels
Key price levels based on recent swing highs and lows across daily and weekly timeframes.
| Level | Daily | Weekly |
|---|---|---|
| 20-Period High | 372.01 | 377.53 |
| 20-Period Low | 318.72 | 293.71 |
| 60-Period High | 408.56 | 408.56 |
| 60-Period Low | 297.34 | 219.82 |
Scenarios
UTHR Technical Scenarios
Conditions, invalidation triggers, and what to watch for each scenario.
Bullish
Trigger
Price breaks above the 20-day high at 372.01 and sustains a move toward the 52-week high at 408.56 with increasing volume.
Invalidation
Price falls below the SMA50 at 332.78 and breaks the 20-day low at 318.72.
What to watch
Daily RSI holding above 55; MACD histogram continuing to expand; volume increasing on break attempts above 372.01; weekly RSI maintaining above 55.
Range-Bound
Trigger
Price oscillates between SMA20 support (340.15) and 372.01 resistance without a decisive breakout.
Invalidation
A decisive close above 372.01 or below SMA20 at 340.15 with above-average volume.
What to watch
RSI staying between 50 and 65; MACD histogram fluctuating around current levels; volume remaining near average; price respecting SMA20 on pullbacks.
Bearish
Trigger
Price breaks below SMA20 (340.15) and SMA50 (332.78) in succession, signaling a loss of short-term momentum.
Invalidation
Price reclaims SMA20 within a few sessions and establishes support above 340.15.
What to watch
Daily RSI falling below 50; MACD histogram turning negative; volume picking up on down days; weekly RSI dropping below 50; any negative company-specific news.
Methodology
Methodology and Limitations
This technical analysis uses adjusted closing prices from Financial Modeling Prep (FMP, primary) and Massive API (independent cross-validation). The daily analysis covers approximately 2 years (502 completed bars) ending July 16, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 13, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.
Frequently Asked Questions
This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 16, 2026, weekly July 13, 2026 week. Generated July 17, 2026.
Related Tools
AI Chart Analyzer
Upload a TradingView chart screenshot and get instant AI-powered technical analysis. Identify patterns, support and resistance, and key levels.
Support and Resistance Calculator
Calculate key support and resistance levels for any stock. Identify potential price zones where reversals or breakouts may occur.
RSI Calculator
Calculate the Relative Strength Index for any stock. Determine overbought and oversold conditions with customizable periods.